Literature DB >> 21254346

Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model.

Kenya Yamanaka1, Etsuro Hatano, Masato Narita, Koji Kitamura, Atsuko Yanagida, Hiroyuki Asechi, Hiromitsu Nagata, Kojiro Taura, Takashi Nitta, Shinji Uemoto.   

Abstract

After extended hepatectomy, excessive shear stress in the remnant liver causes postoperative liver failure. Olprinone (OLP), a selective phosphodiesterase inhibitor, has been reported to improve microcirculation and attenuate inflammation. The aim of this study was to investigate the effects of OLP on shear stress in rats with an excessive hepatectomy (EHx) model. In this study, EHx comprised 90% hepatectomy with ligation of the left and right Glisson's sheaths in Lewis rats. OLP or saline was intraperitoneally administered with an osmotic pump 48 hours before EHx. To evaluate the shear stress, we measured the portal vein (PV) pressure. We also assessed sinusoidal endothelial cell injury by immunohistochemistry and electron microscopy. Furthermore, we assessed apoptosis in the liver with the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling method. Treatment with OLP up-regulated hepatic endothelial nitric oxide synthase (eNOS) expression. The increase in the PV pressure due to Glisson's sheath ligation was attenuated in OLP-treated rats during a 30-minute period after ligation. Treatment with OLP preserved sinusoidal endothelial cells and reduced apoptosis in the remnant liver. The probability of survival in the OLP-treated rats was significantly better than that in the controls (33.3% versus 13.3%). Furthermore, the postoperative eNOS activity in the OLP-treated rats was higher than that in the controls. The administration of Nω-nitro-l-arginine methyl ester to OLP-treated rats eliminated the effects of OLP on PV pressure and survival after EHx. Therefore, we concluded that OLP attenuates excessive shear stress through the up-regulation of eNOS and improves the survival rate after EHx.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254346     DOI: 10.1002/lt.22189

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  11 in total

Review 1.  Novel regulators of endothelial barrier function.

Authors:  Dolly Mehta; Krishnan Ravindran; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-07       Impact factor: 5.464

Review 2.  Post-hepatectomy liver failure in patients with colorectal liver metastases.

Authors:  Masato Narita; Elie Oussoultzoglou; Philippe Bachellier; Daniel Jaeck; Shinji Uemoto
Journal:  Surg Today       Date:  2015-01-29       Impact factor: 2.549

3.  Phase I clinical trial of olprinone in liver surgery.

Authors:  Hiroaki Fuji; Etsuro Hatano; Kohta Iguchi; Kenya Yamanaka; Tomoaki Yoh; Yoshinobu Ikeno; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Shiro Tanaka; Hisanari Ishii; Mariko Kobayashi; Kazuyuki Ueno; Shinji Uemoto
Journal:  Surg Today       Date:  2016-12-27       Impact factor: 2.549

Review 4.  New paradigms in post-hepatectomy liver failure.

Authors:  Nicolas Golse; Petru O Bucur; René Adam; Denis Castaing; Antonio Sa Cunha; Eric Vibert
Journal:  J Gastrointest Surg       Date:  2012-11-18       Impact factor: 3.452

5.  The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma.

Authors:  Kohta Iguchi; Etsuro Hatano; Kenya Yamanaka; Shiro Tanaka; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

6.  Effect of fluid shear stress on portal vein remodeling in a rat model of portal hypertension.

Authors:  Bin Wen; Jian Liang; Xin Deng; Ran Chen; Peichun Peng
Journal:  Gastroenterol Res Pract       Date:  2015-03-29       Impact factor: 2.260

7.  Effects of splanchnic vasoconstrictors on liver regeneration and survival after 90% rat hepatectomy.

Authors:  Dong-Sik Kim; Woong Bae Ji; Jae Hyun Han; Yoon Young Choi; Hyun-Jin Park; Young-Dong Yu; Ju Young Kim
Journal:  Ann Surg Treat Res       Date:  2018-02-28       Impact factor: 1.859

8.  SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.

Authors:  Takayuki Kawai; Kentaro Yasuchika; Takamichi Ishii; Yuya Miyauchi; Hidenobu Kojima; Ryoya Yamaoka; Hokahiro Katayama; Elena Yukie Yoshitoshi; Satoshi Ogiso; Sadahiko Kita; Katsutaro Yasuda; Ken Fukumitsu; Junji Komori; Etsuro Hatano; Yoshiya Kawaguchi; Shinji Uemoto
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

Review 9.  Post hepatectomy liver failure - A comprehensive review of current concepts and controversies.

Authors:  S Ray; N N Mehta; A Golhar; S Nundy
Journal:  Ann Med Surg (Lond)       Date:  2018-08-23

10.  Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway.

Authors:  Jun Ding; Chuang Qi; Jinmao Li; Chuying Huang; Jiayao Zhang; Yong Zhang; Yi Li; Bin Fan
Journal:  Med Sci Monit       Date:  2021-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.